Acrobiosystems Co Ltd
SZSE:301080

Watchlist Manager
Acrobiosystems Co Ltd Logo
Acrobiosystems Co Ltd
SZSE:301080
Watchlist
Price: 45.01 CNY -1.4%
Market Cap: 5.4B CNY
Have any thoughts about
Acrobiosystems Co Ltd?
Write Note

Relative Value

The Relative Value of one Acrobiosystems Co Ltd stock under the Base Case scenario is 69.26 CNY. Compared to the current market price of 45.01 CNY, Acrobiosystems Co Ltd is Undervalued by 35%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
69.26 CNY
Undervaluation 35%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
74
vs Industry
52
Median 3Y
15.8
Median 5Y
15.8
Industry
8.1
Forward
8.6
vs History
43
vs Industry
6
Median 3Y
41.2
Median 5Y
41.2
Industry
23
Forward
35.1
vs History
20
vs Industry
4
Median 3Y
50.3
Median 5Y
50.3
Industry
23.4
vs History
0
vs Industry
1
Median 3Y
86.8
Median 5Y
86.8
Industry
27.3
vs History
71
vs Industry
49
Median 3Y
3.1
Median 5Y
3.1
Industry
2.6
vs History
82
vs Industry
45
Median 3Y
12.1
Median 5Y
12.1
Industry
8.1
Forward
5.6
vs History
82
vs Industry
43
Median 3Y
13.3
Median 5Y
13.3
Industry
9.6
vs History
46
vs Industry
2
Median 3Y
47.4
Median 5Y
47.4
Industry
4.3
Forward
24.5
vs History
46
vs Industry
2
Median 3Y
47.4
Median 5Y
47.4
Industry
3.8
Forward
23.1
vs History
53
vs Industry
4
Median 3Y
39
Median 5Y
39
Industry
6
vs History
vs Industry
Median 3Y
-52.7
Median 5Y
-52.7
Industry
3.8
vs History
66
vs Industry
50
Median 3Y
8.5
Median 5Y
8.5
Industry
4.8

Multiples Across Competitors

Competitors Multiples
Acrobiosystems Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Acrobiosystems Co Ltd
SZSE:301080
5.5B CNY 9.4 45.4 53.1 53.1
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 380 957.8 -177 666.1 -215 743.3 -213 281.4
US
Abbvie Inc
NYSE:ABBV
302.3B USD 5.4 59.5 14.9 22.9
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 4.9 38 17.7 33.4
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
126.3B USD 11.9 -263.2 26.7 28
US
Gilead Sciences Inc
NASDAQ:GILD
117.6B USD 4.2 933 10.4 10.4
US
Epizyme Inc
F:EPE
94.1B EUR 1 884.6 -480.9 -523.7 -509.7
AU
CSL Ltd
ASX:CSL
138.5B AUD 6.1 34.3 21.1 26.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
90.4B USD 6.5 19.4 17.9 19.9
US
Seagen Inc
F:SGT
39.3B EUR 18.2 -55.7 -59.8 -54
NL
argenx SE
XBRU:ARGX
33.4B EUR 18.2 -127.9 -102.8 -74.9
P/E Multiple
Earnings Growth
CN
Acrobiosystems Co Ltd
SZSE:301080
Average P/E: 188.3
45.4
54%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -177 666.1 N/A
US
Abbvie Inc
NYSE:ABBV
59.5
412%
US
Amgen Inc
NASDAQ:AMGN
38
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -263.2
42%
US
Gilead Sciences Inc
NASDAQ:GILD
933
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -480.9 N/A
AU
CSL Ltd
ASX:CSL
34.3
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.4
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -55.7 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -127.9 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
Acrobiosystems Co Ltd
SZSE:301080
Average EV/EBITDA: 23.1
53.1
142%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -215 743.3 N/A
US
Abbvie Inc
NYSE:ABBV
14.9
28%
US
Amgen Inc
NASDAQ:AMGN
17.7
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
26.7
38%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -523.7 N/A
AU
CSL Ltd
ASX:CSL
21.1
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.8 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -102.8 N/A
EV/EBIT Multiple
EBIT Growth
CN
Acrobiosystems Co Ltd
SZSE:301080
Average EV/EBIT: 27.7
53.1
157%
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -213 281.4 N/A
US
Abbvie Inc
NYSE:ABBV
22.9
88%
US
Amgen Inc
NASDAQ:AMGN
33.4
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
28
44%
US
Gilead Sciences Inc
NASDAQ:GILD
10.4
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -509.7 N/A
AU
CSL Ltd
ASX:CSL
26.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
19.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -74.9 N/A

See Also

Discover More
Back to Top